Various recent events and developments have influenced the valuation of Corteva (CTVA), including robust Q3 results, raised outlook for 2025, and the announcement of a seed business spin-off. Financial institutions such as Vise Technologies, PNC Financial Services Group, Geode Capital Management, Boston Partners, Ironwood Investment Counsel, national pension services, and Illinois Municipal Retirement Fund have either purchased or sold shares of Corteva, altering their stakes significantly. The agricultural biotechnology company has announced a quarterly dividend of $0.18. Further, Wells Fargo and RBC Capital has maintained the company's rating, but revised the target price. The company also declared plans to split into two separate companies, namely Crop Protection and Pioneer Seeds Division, which led to mixed market sentiments. Alongside, Corteva announced the launch of a new bioinsecticide, Goltrevo, showcasing innovation in sustainable crop protection. However, there is some uncertainty due to this strategic business splitting, leading Citi to downgrade the CTVA outlook for 2026.
Corteva CTVA News Analytics from Mon, 02 Jun 2025 07:00:00 GMT to Sat, 15 Nov 2025 15:14:14 GMT -
